EryDel
Desconocido
IEDAT: Intra Erythrocyte Dexamethasone in the treatment of Ataxia Telangiectasia
ERYDEL SPA
tramitó un
H2020:
H2020-PHC-2014-2015
The main objective of the project is to provide a treatment of the neurological symptoms of patients with Ataxia Telangiectasia (AT), a rare...
2015-12-09 - 2021-08-31 | Financiado
2015-12-09 - 2021-08-31 | Financiado
* No se disponen de datos de la empresa actual.